In this situation it was our aim to investigate whether the well-characterized MTH1 inhibitor TH588 has detrimental effects on cultured colorectal carcinoma cells and whether these effects are attributable to MTH1 inhibition. This evidence concerns the gene NUDT1 and colorectal carcinoma.